Article
ASO targeting temperature-controlled <i>RBM3</i> poison exon splicing prevents neurodegeneration in vivo
2022-10-26
Abstract excerpt
<h4>Summary</h4> Neurodegenerative diseases are increasingly prevalent in the aging population, yet currently no disease-modifying treatments are available. Increasing the expression of the cold-shock protein, RBM3, through therapeutic hypothermia is remarkably neuroprotective, but cooling poses a health risk itself, strongly limiting its clinical application. Selective upregulation of RBM3 at normothermia thus h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e5ed7707-1f5b-51fc-bca8-58be336a9bd7
- DOI
- 10.1101/2022.10.26.513170
